Management of Patients with Vulvar Cancers: A Systematic Comparison of International Guidelines (NCCN-ASCO-ESGO-BGCS-IGCS-FIGO-French Guidelines-RCOG)
- PMID: 39857968
- PMCID: PMC11764181
- DOI: 10.3390/cancers17020186
Management of Patients with Vulvar Cancers: A Systematic Comparison of International Guidelines (NCCN-ASCO-ESGO-BGCS-IGCS-FIGO-French Guidelines-RCOG)
Abstract
Background: Vulvar carcinoma is an uncommon gynecological tumor primarily affecting older women. Its treatment significantly impacts the quality of life and, not least, aesthetics because of the mutilating surgery it requires.
Objectives: The management requires a multidisciplinary team of specialists who know how to care for the patient in her entirety, not neglecting psychological aspects and reconstructive surgery. How do the guidelines address multidisciplinarity, team surgical management, passing through preoperative diagnosis, and follow-up in such a challenging rare tumor to treat?
Methods: To answer these questions, we compared the main scientific recommendations to identify similarities and differences in diagnostic and therapeutic management to provide an overview of the gaps that there are currently in European and American international recommendations in providing management guidance in a cancer that is both among the rarest and most difficult to manage. In this way, we aim to encourage an update in practices based on the latest scientific evidence.
Results: A review of various international guidelines, some dating back to 2014, shows significant variation in approaches, ranging from initial diagnostic procedures to managing relapses. The most recent guidelines also lacked references to the latest literature, indicating that more robust scientific evidence is needed before new treatments, such as electrochemotherapy for palliation and reconstructive surgery post exenteration, can be widely adopted.
Conclusions: From the systematic comparison of the main international guidelines, a strong heterogeneity emerged in the diagnostic and therapeutic recommendations as well as for the multidisciplinary approach that today is essential. Our work certainly stimulated an update of the main guidelines.
Keywords: disease management; guidelines; review literature; vulvar cancer.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Management for Cervical Cancer Patients: A Comparison of the Guidelines from the International Scientific Societies (ESGO-NCCN-ASCO-AIOM-FIGO-BGCS-SEOM-ESMO-JSGO).Cancers (Basel). 2024 Jul 15;16(14):2541. doi: 10.3390/cancers16142541. Cancers (Basel). 2024. PMID: 39061181 Free PMC article. Review.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma.Hum Reprod Open. 2023 Feb 6;2023(1):hoac057. doi: 10.1093/hropen/hoac057. eCollection 2023. Hum Reprod Open. 2023. PMID: 36756380 Free PMC article.
-
European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023.Int J Gynecol Cancer. 2023 Jul 3;33(7):1023-1043. doi: 10.1136/ijgc-2023-004486. Int J Gynecol Cancer. 2023. PMID: 37369376 Free PMC article.
-
[Management of the nodal disease in vulvar cancers. The ESGO guidelines].Bull Cancer. 2020 Jun;107(6):715-720. doi: 10.1016/j.bulcan.2019.06.010. Epub 2019 Oct 2. Bull Cancer. 2020. PMID: 31586525 Review. French.
Cited by
-
Editorial: Diagnosis and treatment of vulvar cancer.Front Oncol. 2025 Mar 4;15:1569255. doi: 10.3389/fonc.2025.1569255. eCollection 2025. Front Oncol. 2025. PMID: 40104494 Free PMC article. No abstract available.
-
[Description of alarm symptoms in women with gynecologic cancer].Aten Primaria. 2025 Jul 15;57(12):103337. doi: 10.1016/j.aprim.2025.103337. Online ahead of print. Aten Primaria. 2025. PMID: 40669124 Free PMC article. Spanish.
-
Reconstruction of the Vulva and Perineum-Comparison of Surgical Methods.J Clin Med. 2025 Jun 23;14(13):4456. doi: 10.3390/jcm14134456. J Clin Med. 2025. PMID: 40648830 Free PMC article. Review.
-
Trend, Epidemiology, and Clinical Characteristics of Vulvar Cancers in Lagos, Nigeria: A Facility-Based Study.Cureus. 2025 Apr 26;17(4):e83041. doi: 10.7759/cureus.83041. eCollection 2025 Apr. Cureus. 2025. PMID: 40421330 Free PMC article.
References
-
- World Health Organization International Agency for Research on Cancer. Cancer Today. [(accessed on 8 August 2024)]. Available online: https://gco.iarc.fr/today/data/factsheets/cancers/21-Vulva-fact-sheet.pdf.
-
- SEER Cancer Statistics Factsheets: Vulvar Cancer. Bethesda, MD: National Cancer Institute. [(accessed on 8 November 2023)]; Available online: http://seer.cancer.gov/statfacts/html/vulva.html.
-
- Darwish A., Ismail L., Manek S., Hellner K., Kehoe S., Majd H.S. Prognostic characteristics, recurrence patterns, and survival outcomes of vulval squamous cell carcinoma—A twelve-year retrospective analysis of a tertiary centre. Eur. J. Surg. Oncol. 2024;50:108447. doi: 10.1016/j.ejso.2024.108447. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources